Upjohn Caverject direct-to-consumer ads to appear in 30 publications starting in November.
Executive Summary
UPJOHN CAVERJECT DIRECT-TO-CONSUMER ADS TO DEBUT IN NOVEMBER in 30 publications as part of national print campaign. Upjohn initiated its promotional campaign for the erectile dysfunction product alprostadil injection during the week of Aug. 28, with video news releases available for television news programs the evening of Aug. 30. Caverject received FDA approval July 6.